Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Diabetes Mellitus on Vascular Healing Process After Everolimus-Eluting Stent Implantation: An Optical Coherence Tomography Study.
Hioki H, Brugaletta S, Gomez-Lara J, Romaguera R, Fuentes L, Cequier A, Herrera R, Jimenez-Quevedo P, Otsuki S, Masotti M, Sabaté M. Hioki H, et al. Among authors: brugaletta s. Cardiovasc Revasc Med. 2022 Feb;35:44-50. doi: 10.1016/j.carrev.2021.04.012. Epub 2021 Apr 16. Cardiovasc Revasc Med. 2022. PMID: 33879410
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
Brugaletta S, Garcia-Garcia HM, Garg S, Gomez-Lara J, Diletti R, Onuma Y, van Geuns RJ, McClean D, Dudek D, Thuesen L, Chevalier B, Windecker S, Whitbourn R, Dorange C, Miquel-Hebert K, Sudhir K, Ormiston JA, Serruys PW. Brugaletta S, et al. Int J Cardiovasc Imaging. 2011 Jul;27(6):859-66. doi: 10.1007/s10554-010-9724-y. Epub 2010 Oct 13. Int J Cardiovasc Imaging. 2011. PMID: 20941544 Free article. Clinical Trial.
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
Gomez-Lara J, Brugaletta S, Diletti R, Garg S, Onuma Y, Gogas BD, van Geuns RJ, Dorange C, Veldhof S, Rapoza R, Whitbourn R, Windecker S, Garcia-Garcia HM, Regar E, Serruys PW. Gomez-Lara J, et al. Among authors: brugaletta s. Eur Heart J. 2011 Feb;32(3):294-304. doi: 10.1093/eurheartj/ehq458. Epub 2010 Dec 1. Eur Heart J. 2011. PMID: 21123276 Free article.
Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.
Martin-Yuste V, Brugaletta S, Ferreira-González I, Cola C, Alvarez-Contreras L, de Antonio M, Martí V, García-Picart J, Sabaté M. Martin-Yuste V, et al. Among authors: brugaletta s. EuroIntervention. 2011 Feb;6(7):831-7. doi: 10.4244/EIJV6I7A143. EuroIntervention. 2011. PMID: 21252017
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
Brugaletta S, Garcia-Garcia HM, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin ES, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston JA, Serruys PW. Brugaletta S, et al. EuroIntervention. 2011 Apr;6(9):1110-6. doi: 10.4244/EIJV6I9A193. EuroIntervention. 2011. PMID: 21518685 Clinical Trial.
385 results